CRISPR/Cas9-based gene-editing technology for sickle cell disease. Ma L, Yang S, Peng Q, Zhang J, et al. Gene 2023;874:147480.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ma L, Yang S, Peng Q, Zhang J, et al. CRISPR/Cas9-based gene-editing technology for sickle cell disease. Gene 2023;874:147480.
PMID: 37182559